MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.
News-Medical.Net on MSN
New trial aims to improve both survival and quality of life for men with advanced prostate cancer
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...
SurvivorNet on MSN
Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients
Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...
A recently published study found that targeted radiation delivered before surgery can eradicate certain early-stage ...
An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing surveillance, emphasizing the importance of reporting unexpected adverse events to ...
Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
FOX 13 Tampa Bay on MSN
USF researchers develop tumor-targeting cancer treatment already saving pets: Human trials could be next
USF medical engineering professors Dr. Richard Heller and Dr. Mark Jaroszeski have spent more than three decades developing a targeted cancer-treatment technology that avoids traditional chemotherapy ...
Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback